Alkeon Capital Management LLC Acquires 550,000 Shares of Lam Research Corporation $LRCX

Alkeon Capital Management LLC lifted its holdings in Lam Research Corporation (NASDAQ:LRCX) by 6.9% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 8,504,456 shares of the semiconductor company’s stock after purchasing an additional 550,000 shares during the period. Lam Research comprises 1.4% of Alkeon Capital Management LLC’s holdings, making the stock its 11th biggest position. Alkeon Capital Management LLC’s holdings in Lam Research were worth $827,824,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the business. IMG Wealth Management Inc. bought a new position in Lam Research in the second quarter worth approximately $26,000. Howard Hughes Medical Institute purchased a new position in shares of Lam Research in the 2nd quarter valued at $27,000. Strategic Wealth Investment Group LLC purchased a new position in shares of Lam Research in the 2nd quarter valued at $29,000. REAP Financial Group LLC bought a new position in shares of Lam Research in the 2nd quarter worth $31,000. Finally, 1 North Wealth Services LLC purchased a new stake in shares of Lam Research during the 1st quarter worth $36,000. 84.61% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

LRCX has been the topic of several analyst reports. Hsbc Global Res upgraded Lam Research to a “hold” rating in a research note on Tuesday, September 30th. Cantor Fitzgerald reissued an “overweight” rating and set a $170.00 price target on shares of Lam Research in a research report on Thursday, October 23rd. Susquehanna lifted their price objective on shares of Lam Research from $135.00 to $200.00 and gave the stock a “positive” rating in a research report on Thursday, October 23rd. Citigroup boosted their price objective on shares of Lam Research from $175.00 to $190.00 and gave the stock a “buy” rating in a research note on Tuesday, November 11th. Finally, Sanford C. Bernstein increased their target price on shares of Lam Research from $170.00 to $175.00 and gave the company an “outperform” rating in a research report on Friday, November 21st. Twenty-six research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $152.87.

Lam Research Trading Down 4.9%

NASDAQ LRCX opened at $160.52 on Friday. Lam Research Corporation has a 12-month low of $56.32 and a 12-month high of $169.69. The company has a fifty day simple moving average of $152.53 and a two-hundred day simple moving average of $119.99. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37. The stock has a market cap of $201.62 billion, a P/E ratio of 35.36, a P/E/G ratio of 1.73 and a beta of 1.77.

Lam Research (NASDAQ:LRCX) last released its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.22 by $0.04. The firm had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.23 billion. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The firm’s revenue was up 27.7% on a year-over-year basis. During the same period in the prior year, the firm earned $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. On average, analysts forecast that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd will be paid a $0.26 dividend. This represents a $1.04 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Wednesday, December 3rd. Lam Research’s dividend payout ratio (DPR) is presently 22.91%.

Insider Transactions at Lam Research

In related news, SVP Vahid Vahedi sold 52,190 shares of Lam Research stock in a transaction dated Monday, October 13th. The stock was sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the completion of the sale, the senior vice president owned 251,047 shares of the company’s stock, valued at $34,870,428.30. The trade was a 17.21% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Douglas R. Bettinger sold 40,080 shares of the company’s stock in a transaction that occurred on Friday, November 14th. The shares were sold at an average price of $150.60, for a total value of $6,036,048.00. Following the completion of the sale, the chief financial officer owned 987,237 shares in the company, valued at approximately $148,677,892.20. This represents a 3.90% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 102,608 shares of company stock valued at $14,916,496. 0.31% of the stock is owned by company insiders.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.